Document is current

Any future updates will be listed below

Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma

Crossref DOI link: https://doi.org/10.1007/s11060-016-2206-x

Published Online: 2016-07-15

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark